載入...
Cost effectiveness of tac versus fac in adjuvant treatment of node-positive breast cancer
BACKGROUND: This economic analysis aimed to determine, from the perspective of a Canadian provincial government payer, the cost-effectiveness of docetaxel (Taxotere: Sanofi–Aventis, Laval, QC) in combination with doxorubicin and cyclophosphamide (tac) compared with 5-fluorouracil, doxorubicin, and c...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Multimed Inc.
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2826781/ https://ncbi.nlm.nih.gov/pubmed/20179798 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|